PMID: 9167759Jun 1, 1997Paper

Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma

American Journal of Clinical Oncology
M ColleoniP Manente

Abstract

Brain metastases represent a common complication of breast and lung cancer, with an overall incidence exceeding 30-40% of cases. Results achieved with radiotherapy are disappointing, with a median survival of a few months, and no clear activity has been observed with chemotherapy. The aims of this study were to assess the activity and feasibility of a new chemotherapeutic approach according to the following schedule: lomustine, 80 mg/m2 day 1; carboplatin, 80 mg/m2 days 1, 8, 15, 22; vinorelbine, 20 mg/m2 days 1, 8, 15, 22; L-leucovorin 250 mg/m2 days 1, 8, 15, 22; and fluorouracil, 500 mg/m2 days 1, 8, 15, 22. Cycles were repeated every 6 weeks. Since January 1994, 28 patients have been enrolled and 26 are evaluable for response and side effects. Major patient characteristics were median age, 55 years (range 31-72); men/women 15/11; lung primary, 20; breast primary, 6; performance status Eastern Cooperative Oncology Group, 0-2. A total of 64 cycles were administered (median/patient, two cycles). Nine partial remissions have been observed (35%, 95% confidence interval 17-56%), 6 disease stabilizations, and 11 disease progressions. Median duration of response was 3 months, and median time to progression for the whole group was 3...Continue Reading

References

Nov 1, 1979·Cancer·A DiStefanoG R Blumenschein
Sep 1, 1977·Archives of Neurology·N A VickD D Bigner
Aug 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J HildebrandY Kenis
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·M G DonelliM D'Incalci
Feb 15, 1992·Cancer·W BoogerdJ J van der Sande
Jan 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C J Twelves, R L Souhami
Jan 1, 1989·Seminars in Surgical Oncology·J A Smith
Feb 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·J HortonK B Olson
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·B BorgeltF R Hendrickson
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·J West, M Maor
Jan 1, 1983·Journal of Neuro-oncology·D RosnerW Lane
Jul 1, 1980·Annals of Internal Medicine·E A Neuwelt, E P Frenkel
Jun 1, 1980·Annals of Neurology·J G CairncrossJ B Posner
Jan 1, 1994·Cancer Investigation·L M DeAngelis

❮ Previous
Next ❯

Citations

Mar 26, 2005·World Journal of Urology·Alexander MuacevicBerndt Wowra
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K GrüschowR Fietkau
Nov 28, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M J Gil-GilS Villà
Oct 30, 2007·Neurologic Clinics·Teri D Nguyen, Lisa M DeAngelis
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Leyland-Jones
May 10, 2005·Expert Review of Anticancer Therapy·Michelle E MeliskoJohn W Park
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·O EngebraatenO Fodstad
Oct 11, 2005·Journal of Neuro-oncology·R SoffiettiR Rudà
Oct 21, 2005·Neurosurgery·David M Peereboom
May 8, 2002·CNS Drugs·Phillip Davey
Sep 13, 2007·Journal of Neuro-oncology·Kazuhiko OgawaSadayuki Murayama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.